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AIM
 Cardiogenic shock (CS) remains the most serious clinical complication and the leading
cause of death for patients with an acute coronary syndrome (ACS).
 Despite recent studies suggesting possible declines in the risk of dying during
hospitalization for patients with CS, which has been linked to advances in medical
treatment and coronary revascularization techniques, in-hospital mortality associated with
CS remains high.
INTRODUCTION
 Determine characteristics and management of patients with an ACS complicated by CS.




• 2064 patients consecutively admitted for ACS 
in a coronary unit over a period of 4 years.
CS
definition
• Systolic blood pressure  < 90 mmHg in 
the absence of hypovolaemia and 
associated with signs of poor 
peripheral perfusion.
Primary
endpoint • In-hospital mortality
Retrospective study
RESULTS
 According to the literature, our review showed that CS in the context of ACS is associated with a high mortality.
 We identified clinical markers that are associated with the development of CS and may spot patients at risk earlier.
 Absence of coronary revascularization remains an independent predictor of mortality in CS.
CONCLUSION
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NT-proBNP (pg/ml, mean ± sd)
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Table 1 - Baseline patients characteristics















































STEMI 4.1 (2.0-8.0) < 0.001
Tachycardia 3.2 (1.6-6.3) 0.001
SBP < 100 mmHg 4.1 (2.1-8.0) < 0.001
eGFR <60 
ml/min/1.73m2
2.5 (1.2-5.2) < 0.001
Killip class 2-3 3.5 (1.8-6.8) < 0.001

















Ventricular arrhythmias Stent thrombosis Stroke Death
CS + CS -
The in-hospital mortality of patients with CS was 45%, compared with 1.7% in those 
who did not develop CS. 
Table 3 – Predictors of occurrence of CS during hospitalization 
OR (CI95%) p
Absence of coronary 
revascularization 
4.9 (1.5-16) 0.004
LVEF ≤ 35% 3.9 (1.3-12.4) 0.006
Advanced age 6.4 (1.6-26.2) 0.003
eGFR <60 ml/min/1.73m2 4.4 (1.3-15.6) 0.001
Table 4 –Predictors of in-hospital mortaluty
p <0.001
p <0.001
NSNS
(%)
